Comorbidity of depression with other medical diseases in the elderly (Q34934375)

5 August 2017

1 reference

title

Comorbidity of depression with other medical diseases in the elderly (English)

1 reference

5 August 2017

1 reference

Helena Chmura Kraemer

3

object named as

Helena Kraemer

1 reference

5 August 2017

8

Mary Dew

1 reference

5 August 2017

7

William McDonald

1 reference

5 August 2017

2

Mahlon Delong

1 reference

5 August 2017

K Ranga R Krishnan

1

1 reference

5 August 2017

Robert Carney

4

1 reference

5 August 2017

David Spiegel

5

1 reference

5 August 2017

Christopher Gordon

6

1 reference

5 August 2017

George Alexopoulos

9

1 reference

5 August 2017

Kathleen Buckwalter

10

1 reference

5 August 2017

Perry D Cohen

11

1 reference

5 August 2017

Dwight Evans

12

1 reference

5 August 2017

Peter G Kaufmann

13

1 reference

5 August 2017

Jason Olin

14

1 reference

5 August 2017

Emeline Otey

15

1 reference

5 August 2017

Cynthia Wainscott

16

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 September 2002

1 reference

5 August 2017

Biological Psychiatry

1 reference

5 August 2017

52

1 reference

5 August 2017

6

1 reference

5 August 2017

559-588

1 reference

Biobehavioral variables and mortality or cardiac arrest in the Cardiac Arrhythmia Pilot Study (CAPS).

5 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

The multidimensional nature of cancer-related pain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

'Vascular depression' hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Geriatric depression: Age of onset and dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Effects of antidepressants on cognitive functions: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Stress and immune responses after surgical treatment for regional breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

A biobehavioral model of cancer stress and disease course

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

7 January 2021

Anti-depressive treatment in Parkinson's disease. A controlled trial of the effect of nortriptyline in patients with Parkinson's disease treated with L-DOPA

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Inflammation, depressive symptomtology, and coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Prevalence of psychiatric disorders among men infected with human immunodeficiency virus. A controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Cobalamin level is related to self-reported and clinically rated mood and to syndromal depression in bereaved HIV-1(+) and HIV-1(-) homosexual men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Depression and long-term mortality risk in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Symptoms of depression, acute myocardial infarction, and total mortality in a community sample.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Starting again--a comparison study of a group rehabilitation program for cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Late-life suicide: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

The prevalence and distribution of major depression in a national community sample: the National Comorbidity Survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

A randomized, double-blind, placebo-controlled trial of psychostimulants for the treatment of fatigue in ambulatory patients with human immunodeficiency virus disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Memory processes and the course of anxiety and depression in cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Didanosine-induced mania in HIV infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Prediction of outcome after coronary artery surgery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Depression in hospitalized cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Electroconvulsive Therapy in the Treatment of Combined Depression and Parkinson's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Even minimal symptoms of depression increase mortality risk after acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Psychosocial benefits of a cancer support group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Depression increases post-Mi mortality: how?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Insomnia and depression prior to myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Depression as a risk factor for cardiac events in established coronary heart disease: a review of possible mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Major depressive disorder predicts cardiac events in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Major depressive disorder in coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Apathy, depression, and cognitive performance in HIV-1 infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

The prevalence of emotional and cognitive dysfunction in a general medical population: using the MMSE, GHQ, and BDI.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Psychological status during recovery from an acute heart attack

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Paroxetine in Parkinson's disease: effects on motor and depressive symptoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Medication Adherence Among HIV-Infected Patients: Understanding the Complex Behavior of Patients Taking This Complex Therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Lifetime prevalence of substance or alcohol abuse and dependence among subjects with bipolar I and II disorders in a voluntary registry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Coping effectiveness training for men living with HIV: preliminary findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Desire for death in the terminally ill

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

The impact of pain on the patient with cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Electroconvulsive therapy of depression in patients with white matter hyperintensity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Depression and Parkinson's disease: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Suicide and HIV infection. Mortality follow-up of 4147 HIV-seropositive military service applicants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Fatigue, sleep disturbance, disability, and indices of progression of HIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

The prevalence and severity of pain in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Epstein-Barr virus and depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

The prevalence of psychiatric disorders among cancer patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Diurnal activity and pulsatility of the hypothalamus-pituitary-adrenal system in male depressed patients and healthy controls.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Prevalence and predictors of depressive, anxiety and substance use disorders in HIV-infected and uninfected men: a longitudinal evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Early post-transplant medical compliance and mental health predict physical morbidity and mortality one to three years after heart transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Prevalence and predictors of depression and anxiety-related disorders during the year after heart transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Magnetic resonance assessment of cerebral perfusion in depressed cardiac patients: preliminary findings.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

ECT and Parkinson's disease revisited: a "naturalistic" study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Effects of depressive disorders on coronary artery disease: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Multiple pains and psychiatric disturbance. An epidemiologic investigation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Measurement of depression in patients with cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Severe life stress as a predictor of early disease progression in HIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Psychological outcomes in women with early breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

A structured psychiatric intervention for cancer patients. I. Changes over time in methods of coping and affective disturbance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Critical review of psychosocial interventions in cancer care

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Group counseling in adult patients with advanced cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Selective serotonin reuptake inhibitor treatment of depression in symptomatic HIV infection and AIDS. Improvements in affective and somatic symptoms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Depression following myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Depression following myocardial infarction. Impact on 6-month survival.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Depression and 18-month prognosis after myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Major depression in coronary artery disease patients with vs. without a prior history of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Depression and the course of coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Bupropion in Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

The relationship of mood, endocrine, and sexual disorders in human immunodeficiency virus positive (HIV+) women: an exploratory study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Depression in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Sociodemographic and psychological variables influencing adherence to antiretroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Reliability of psychiatric scales in patients with dementia of the Alzheimer type.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Notes on the use of fluvoxamine as treatment of depression in HIV-1-infected subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Prevalence of posttraumatic stress disorder in women with breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Treatment of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Effects of testosterone and progressive resistance training in eugonadal men with AIDS wasting. A randomized, controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: the Multimodal Treatment Study of children with Attention-deficit/hyperactivity disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Depression in patients with coronary heart disease. A 12-month follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Sertraline for the treatment of depression in Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Stress and immunity in humans: a meta-analytic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Impaired in vivo immune responses in patients with melancholia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

A controlled trial of fluoxetine and desipramine in depressed women with advanced cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Predictors of self-reported adherence in persons living with HIV disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Psychiatric morbidity in patients with advanced cancer of the breast: prevalence measured by two self-rating questionnaires

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Depression among cancer patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Ritonavir. Clinical pharmacokinetics and interactions with other anti-HIV agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

A 10-year study of the incidence of and factors predicting dementia in Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Psychogenic factors in predicting survival of breast cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Predicting completeness of symptom relief after major heart surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Depression and heart disease: evidence of a link, and its therapeutic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Parkinsonism exacerbated by paroxetine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Psychiatric history and related exposures as risk factors for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Depressive symptoms reduced in individuals with HIV/AIDS treated with highly active antiretroviral therapy: a longitudinal study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Depression and thoughts of suicide among middle-aged and older persons living with HIV-AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Distinguishing between overlapping somatic symptoms of depression and HIV disease in people living with HIV-AIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Diagnosing depression in patients with medical illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Examining the validity of DSM-III-R schizoaffective disorder and its putative subtypes in the Roscommon Family Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Gender and schizophrenia. Results of an epidemiologically-based family study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Depression in hospitalized older patients with congestive heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Statistical issues in assessing comorbidity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

How do risk factors work together? Mediators, moderators, and independent, overlapping, and proxy risk factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

How can we learn about developmental processes from cross-sectional studies, or can we?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Neuroanatomical substrates of depression in the elderly.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

MRI-defined vascular depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Professionally-led support groups for cancer patients: an intervention in search of a model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

The motor performance test series in Parkinson's disease is influenced by depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Factors which provoke post-infarction depression: results from the post-infarction late potential study (PILP)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Desipramine in treatment of Parkinson's disease. A placebo-controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Absence of major depressive disorder in female cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Depression and 1-year prognosis in unstable angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Major depression before and after myocardial infarction: its nature and consequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Illness characteristics and their association with prescription patterns for bipolar I disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Mental disorders in cancer patients: a study of 100 psychiatric referrals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Correlation of stress factors with sustained depression of natural killer cell activity and predicted prognosis in patients with breast cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Nortriptyline for post-stroke depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Nortriptyline treatment of post-stroke depression: a double-blind study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

The correlation of depression with functional activity in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Distress or illness? A study of psychological symptoms after myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Depressive symptoms as predictors of medical outcomes in HIV infection. Multicenter AIDS Cohort Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Depressive syndromes and causal associations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Natural killer cell activity in major depression: Relation to circulating natural killer cells, cellular indices of the immune response, and depressive phenomenology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Improving the detection of psychiatric problems in cancer patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

The sources of convergence between measures of apathy and depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Treatment of depressive symptoms in human immunodeficiency virus-positive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Neuropsychiatric aspects of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

The cancer patient with pain: psychiatric complications and their management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Depression, intellectual impairment, and Parkinson disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Clinical and biochemical features of depression in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Psychosocial adjustment in patients one year after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Serotonergic dysfunction in depression associated with Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Depression in patients with cancer. Diagnosis, biology, and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Parkinson's disease and depression: the relationship to disability and personality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Secondary mania in patients with HIV infection: are antiretrovirals protective?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Depression, Introversion and Mortality following Stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Newer antidepressants and the cytochrome P450 system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

The clinical efficacy of citalopram in treatment of emotional disturbances in dementia disorders. A Nordic multicentre study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Controlled trial of psychological intervention in myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Effects on quality of life with comprehensive rehabilitation after acute myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Poststroke depression and its role in rehabilitation of inpatients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

The impact of poststroke depression on recovery in activities of daily living over a 2-year follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Antidepressants and the cardiac patient. Selecting an appropriate medication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Depressive phenomena, physical symptom distress, and functional status among women with breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Chronically depressed mood and cancer risk in older persons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Mood disorders in HIV infection: prevalence and risk factors in a nonepicenter of the AIDS epidemic.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Psychopathology in 90 consecutive human immunodeficiency virus-seropositive and acquired immune deficiency syndrome patients with mostly intravenous drug use history.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Comparative studies of psychological function in patients with advanced cancer--I. Self-reported depressive symptoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Relationships among apathy, depression, and cognitive impairment in HIV/AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Suicidality in AIDS long-term survivors: what is the evidence?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Fluoxetine treatment for depression in patients with HIV and AIDS: a randomized, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Testosterone therapy for human immunodeficiency virus-positive men with and without hypogonadism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

The CES-D Scale: A Self-Report Depression Scale for Research in the General Population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Brief Group Therapy in Myocardial Infarction Rehabilitation: Three- to Four-Year Follow-Up of a Controlled Trial*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Functional impairment associated with acute poststroke depression: the Stroke Data Bank Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

The effect of fluoxetine on anxiety and depression symptoms in cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Antidepressant therapy after stroke. A double-blind trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Double-blind trial of imipramine in Alzheimer's disease patients with and without depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

A survey of antidepressant drug use in Parkinson's disease. Parkinson Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Serotonin syndrome and the combined use of deprenyl and an antidepressant in Parkinson's disease. Parkinson Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Do serotonin reuptake inhibitor antidepressants worsen Parkinson's disease? A retrospective case series

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Treatment issues in poststroke depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Pathophysiology of secondary depressions in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Mood disorders in stroke patients. Importance of location of lesion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Mood change following left hemispheric brain injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Suicidal ideation, bereavement, HIV serostatus and psychosocial variables in partners of men with AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Sertraline relieves hot flashes secondary to medical castration as treatment of advanced prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Lifetime panic-depression comorbidity in the National Comorbidity Survey. Association with symptoms, impairment, course and help-seeking

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Selective serotonin reuptake inhibitors and myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Major depressive disorder and immunity. Role of age, sex, severity, and hospitalization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Digitalis and β-blocking agents: Effects on depression following myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

What contributes to quality of life in patients with Parkinson's disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Association between depression and mortality in older adults: the Cardiovascular Health Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Diurnal cortisol rhythm as a predictor of breast cancer survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Psychological Depression and 17-Year Risk of Death from Cancer1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

How safe are serotonin reuptake inhibitors for depression in patients with coronary heart disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Symptom interpretation: implications for delay in HIV testing and care among HIV-infected late middle-aged and older adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Concise assessment for depression (CAD): a brief screening approach to depression in the medically ill

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Impact of improved depression treatment in primary care on daily functioning and disability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Fluoxetine in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Post-stroke depression: relationships to functional impairment, coping strategies, and rehabilitation outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Rethinking medicine: improving health outcomes with cost-effective psychosocial interventions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Inhibition of endothelial vascular cell adhesion molecule-1 expression by nitric oxide involves the induction and nuclear translocation of IkappaBalpha.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Pain in metastatic breast cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Effect of psychosocial treatment on survival of patients with metastatic breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Pain and depression in patients with cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Cognitive impairments and depression in Parkinson's disease: a follow up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Mania after brain injury. A controlled study of causative factors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Depression in classic versus akinetic-rigid Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Depression in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Depression, the immune system, and health and illness. Findings in search of meaning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Multidisciplinary baseline assessment of homosexual men with and without human immunodeficiency virus infection. III. Neurologic and neuropsychological findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Antecedent clinical features associated with dementia in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Efficacy and safety of fluoxetine in the treatment of patients with major depression after first myocardial infarction: findings from a double-blind, placebo-controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

IMIPRAMINE IN TREATMENT OF PARKINSONISM: A DOUBLE-BLIND PLACEBO STUDY

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

A comparison of psychiatric symptoms in vascular dementia and Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Risk factors for depression in Parkinson disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

A double-blind, randomized, fixed-dose trial of fluoxetine vs. amitriptyline in the treatment of major depression complicating Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

L-deprenyl in Alzheimer's disease. Preliminary evidence for behavioral change with monoamine oxidase B inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Imipramine in the treatment of depressed Alzheimer's patients: impact on cognition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Assessment of depression in dementia patients: association of caregiver mood with depression ratings.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Mirtazapine for the treatment of depression and nausea in breast and gynecological oncology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Neuroendocrine aspects of primary endogenous depression: XII. Receiver operating characteristic and kappa analyses of serum and urine cortisol measures in patients and matched controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Rhythm alteration in patients with metastatic breast cancer and poor prognostic factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Depression following myocardial infarction: a one year longitudinal study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Effects of psychological treatment on cancer patients: a critical review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Psychological symptoms and disease-free and overall survival in women with stage II breast cancer. Cancer and Leukemia Group B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Neuropsychological impairment in Parkinson's disease with and without depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Significant interactions with new antiretrovirals and psychotropic drugs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Depression and Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Psychic effects of physical training and relaxation therapy after myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Pharmacological treatment of depression in cancer patients. A placebo-controlled study of mianserin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Cardiovascular effects of tricyclic antidepressants in depressed patients with chronic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

HIV seroprevalence and risk behaviors in psychiatric inpatients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Effects of dextroamphetamine on depression and fatigue in men with HIV: a double-blind, placebo-controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Effects of donepezil on emotional/behavioral symptoms in Alzheimer's disease patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Relationship between quality of life and mood in long-term survivors of breast cancer treated with mastectomy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Multidisciplinary baseline assessment of homosexual men with and without human immunodeficiency virus infection. II. Standardized clinical assessment of current and lifetime psychopathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Overview of depression and psychosis in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

On the use of population-based registries in the clinical validation of genetic tests for disease susceptibility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Cortisol regulation in posttraumatic stress disorder and major depression: a chronobiological analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Development and validation of a geriatric depression screening scale: a preliminary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

Major depression in primary dementia. Clinical and neuropathologic correlates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

The neuropathology of aminergic nuclei in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

The Academy of Psychosomatic Medicine practice guidelines for psychiatric consultation in the general medical setting. The Academy of Psychosomatic Medicine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

7 January 2021

Clinical and neuropathological correlates of depression in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

7 January 2021

Impaired awareness of deficits in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

7 January 2021

Rehabilitation of patients following myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

7 January 2021

Major depression and medication adherence in elderly patients with coronary artery disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

7 January 2021

Cognitive therapy and pharmacotherapy for depression

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

7 January 2021

Implications of HIV treatment advances for behavioral research on AIDS: protease inhibitors and new challenges in HIV secondary prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

7 January 2021

Prognostic risk assessment in primary breast cancer by behavioral and immunological parameters

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

7 January 2021

Group coping skills instruction and supportive group therapy for cancer patients: a comparison of strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901472-5

7 January 2021

10.1016/S0006-3223(02)01472-5

Identifiers

DOI

1 reference

5 August 2017

1 reference